- Home
- WABC vs NVAX Comparison
WABC vs NVAX Comparison
Compare WABC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WABC
- NVAX
- Stock Information
- Founded
- WABC 1972
- NVAX 1987
- Country
- WABC United States
- NVAX United States
- Employees
- WABC N/A
- NVAX N/A
- Industry
- WABC Major Banks
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WABC Finance
- NVAX Health Care
- Exchange
- WABC Nasdaq
- NVAX Nasdaq
- Market Cap
- WABC 1.3B
- NVAX 1.3B
- IPO Year
- WABC N/A
- NVAX 1995
- Fundamental
- Price
- WABC $50.13
- NVAX $5.98
- Analyst Decision
- WABC Hold
- NVAX Buy
- Analyst Count
- WABC 3
- NVAX 6
- Target Price
- WABC $57.00
- NVAX $17.83
- AVG Volume (30 Days)
- WABC 196.5K
- NVAX 3.7M
- Earning Date
- WABC 04-17-2025
- NVAX 05-09-2025
- Dividend Yield
- WABC 3.51%
- NVAX N/A
- EPS Growth
- WABC N/A
- NVAX N/A
- EPS
- WABC 5.20
- NVAX N/A
- Revenue
- WABC $293,248,000.00
- NVAX $682,162,000.00
- Revenue This Year
- WABC N/A
- NVAX N/A
- Revenue Next Year
- WABC N/A
- NVAX $5.13
- P/E Ratio
- WABC $9.65
- NVAX N/A
- Revenue Growth
- WABC N/A
- NVAX N/A
- 52 Week Low
- WABC $45.11
- NVAX $3.81
- 52 Week High
- WABC $59.97
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- WABC 45.29
- NVAX 26.10
- Support Level
- WABC $50.59
- NVAX $7.47
- Resistance Level
- WABC $52.34
- NVAX $7.81
- Average True Range (ATR)
- WABC 1.08
- NVAX 0.35
- MACD
- WABC -0.12
- NVAX -0.19
- Stochastic Oscillator
- WABC 27.78
- NVAX 10.09
About WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California, and all the way east to Nevada County.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.